查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807098

全球无细胞蛋白表达市场成长、规模和趋势分析（按产品、应用、方法和最终用户）—区域展望、竞争策略和细分预测（至 2034 年）

Global Cell- Free Protein Expression Market Growth, Size, Trends Analysis - By Product, By Application, By Method, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 262 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年全球无细胞蛋白表现市场规模将达到 6.8032 亿美元，复合年增长率为 8.86%。

无细胞蛋白质表现技术允许在试管内中合成蛋白质，而无需使用活细胞。此技术不依赖整个生物体的细胞机制，而是利用从大肠桿菌、麦胚或昆虫细胞等细菌中提取的核醣体、tRNA、胺基酸和酵素等成分。这些成分保留了将 DNA 转录为 RNA 并将 RNA 翻译为蛋白质的能力，使研究人员能够在受控环境中快速生产蛋白质。

阻碍因素：全球无细胞蛋白表现市场扩充性有限，是一大挑战。虽然无细胞系统在小规模应用方面效果良好，但难以达到工业化生产所需的高产量。因此，由于需要进行大量的优化并使用大量昂贵的试剂，大规模合成在经济上面临挑战。

本报告调查了全球无细胞蛋白表达市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局以及主要企业的概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动因素、阻碍因素、机会与挑战分析

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争态势

  • 製造地、销售区域、产品类型分布
  • 併购、合作伙伴关係、产品发布和合作

7. 全球无细胞蛋白质表现市场（按产品）

  • 表达系统
  • 试剂

8. 全球无细胞蛋白质表现市场（按应用）

  • 酵素工程
  • 高通量生产
  • 蛋白质标记
  • 蛋白质-蛋白质相互作用
  • 蛋白质纯化

9. 全球无细胞蛋白质表现市场（依方法）

  • 转录和翻译系统
  • 翻译系统

10. 全球无细胞蛋白质表现市场（按最终用户）

  • 製药和生物技术公司
  • 学术研究机构
  • 其他的

第 11 章：全球无细胞蛋白质表现市场

  • 全球市场规模和市场占有率

12. 全球无细胞蛋白质表现市场（按地区）

  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亚
    • 其他的
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美国
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他的

第十三章：公司简介

  • biotechrabbit
  • CellFree Sciences Co., Ltd
  • GeneCopoeia, Inc.
  • Jena Bioscience GmbH
  • Merck KGaA,
  • New England Biolabs
  • Promega Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • 其他的

第十四章 结论

第 15 章简称列表

第 16 章参考链接

简介目录
Product Code: HLCA25235

Global Cell-Free Protein Expression Market Introduction and Overview

According to SPER market research, 'Global Cell-Free Protein Expression Market Size-By Product, By Application, By Method, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Cell-Free Protein Expression Market is predicted to reach 680.32 million by 2034 with a CAGR of 8.86%.

Cell-free protein expression, proteins can be synthesized in vitro without the use of living cells. Instead of depending on the cellular machinery of whole organisms, this technique employs extracted components-such as ribosomes, tRNAs, amino acids, and enzymes-from sources like E. coli, wheat germ, or insect cells. These components preserve the ability to transcribe DNA into RNA and translate RNA into proteins, enabling researchers to generate proteins rapidly and in a controlled environment.

Restraints: The limited scalability of the global cell-free protein expression market poses a major challenge. While cell-free systems work well for small-scale applications, they often struggle to generate the high yields needed for industrial production. This leads to economic difficulties for large-scale synthesis due to the need for extensive optimization and the use of costly reagents in significant amounts.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Application, By Method, By End Use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

biotechrabbit, CellFree Sciences Co., Ltd., GeneCopoeia, Inc., Jena Bioscience GmbH, Merck KGaA, New England Biolabs, Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific, Inc.

Global Cell-Free Protein Expression Market Segmentation:

By Product: Based on the Product, Global Cell-Free Protein Expression Market is segmented as; Expression Systems, Reagents.

By Application: Based on the Application, Global Cell-Free Protein Expression Market is segmented as; Enzyme Engineering, High Throughput Production, Protein Labelling, Protein-Protein Interaction, Protein Purification.

By Method: Based on the Method, Global Cell-Free Protein Expression Market is segmented as; Transcription & Translation systems, Translation systems.

By End Use: Based on the End Use, Global Cell-Free Protein Expression Market is segmented as; Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1.Introduction

  • 1.1.Scope of the report
  • 1.2.Market segment analysis

2.Research Methodology

  • 2.1.Research data source
    • 2.1.1.Secondary Data
    • 2.1.2.Primary Data
    • 2.1.3.SPERs internal database
    • 2.1.4.Premium insight from KOLs
  • 2.2.Market size estimation
    • 2.2.1.Top-down and Bottom-up approach
  • 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

  • 4.1.Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1.Drivers
    • 4.1.2.Restraints
    • 4.1.3.Opportunities
    • 4.1.4.Challenges

5.Market variable and outlook

  • 5.1.SWOT Analysis
    • 5.1.1.Strengths
    • 5.1.2.Weaknesses
    • 5.1.3.Opportunities
    • 5.1.4.Threats
  • 5.2.PESTEL Analysis
    • 5.2.1.Political Landscape
    • 5.2.2.Economic Landscape
    • 5.2.3.Social Landscape
    • 5.2.4.Technological Landscape
    • 5.2.5.Environmental Landscape
    • 5.2.6.Legal Landscape
  • 5.3.PORTERs Five Forces
    • 5.3.1.Bargaining power of suppliers
    • 5.3.2.Bargaining power of buyers
    • 5.3.3.Threat of Substitute
    • 5.3.4.Threat of new entrant
    • 5.3.5.Competitive rivalry
  • 5.4.Heat Map Analysis

6.Competitive Landscape

  • 6.1.Global Cell- Free Protein Expression Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cell- Free Protein Expression Market

7.Global Cell- Free Protein Expression Market, By Product (USD Million) 2021-2034

  • 7.1.Expression Systems
  • 7.2.Reagents

8.Global Cell- Free Protein Expression Market, By Application (USD Million) 2021-2034

  • 8.1.Enzyme Engineering
  • 8.2.High Throughput Production
  • 8.3.Protein Labeling
  • 8.4.Protein-Protein Interaction
  • 8.5.Protein Purification

9.Global Cell- Free Protein Expression Market, By Method (USD Million) 2021-2034

  • 9.1.Transcription & Translation systems
  • 9.2.Translation systems

10.Global Cell- Free Protein Expression Market, By End Use (USD Million) 2021-2034

  • 10.1.Pharmaceutical and Biotechnology Companies
  • 10.2.Academic and Research Institutes
  • 10.3.Others

11.Global Cell- Free Protein Expression Market, (USD Million) 2021-2034

  • 11.1.Global Cell- Free Protein Expression Market Size and Market Share

12.Global Cell- Free Protein Expression Market, By Region, (USD Million) 2021-2034

  • 12.1.Asia-Pacific
    • 12.1.1.Australia
    • 12.1.2.China
    • 12.1.3.India
    • 12.1.4.Japan
    • 12.1.5.South Korea
    • 12.1.6.Rest of Asia-Pacific
  • 12.2.Europe
    • 12.2.1.France
    • 12.2.2.Germany
    • 12.2.3.Italy
    • 12.2.4.Spain
    • 12.2.5.United Kingdom
    • 12.2.6.Rest of Europe
  • 12.3.Middle East and Africa
    • 12.3.1.Kingdom of Saudi Arabia
    • 12.3.2.United Arab Emirates
    • 12.3.3.Qatar
    • 12.3.4.South Africa
    • 12.3.5.Egypt
    • 12.3.6.Morocco
    • 12.3.7.Nigeria
    • 12.3.8.Rest of Middle-East and Africa
  • 12.4.North America
    • 12.4.1.Canada
    • 12.4.2.Mexico
    • 12.4.3.United States
  • 12.5.Latin America
    • 12.5.1.Argentina
    • 12.5.2.Brazil
    • 12.5.3.Rest of Latin America

13.Company Profile

  • 13.1.biotechrabbit
    • 13.1.1.Company details
    • 13.1.2.Financial outlook
    • 13.1.3.Product summary
    • 13.1.4.Recent developments
  • 13.2.CellFree Sciences Co., Ltd
    • 13.2.1.Company details
    • 13.2.2.Financial outlook
    • 13.2.3.Product summary
    • 13.2.4.Recent developments
  • 13.3.GeneCopoeia, Inc.
    • 13.3.1.Company details
    • 13.3.2.Financial outlook
    • 13.3.3.Product summary
    • 13.3.4.Recent developments
  • 13.4.Jena Bioscience GmbH
    • 13.4.1.Company details
    • 13.4.2.Financial outlook
    • 13.4.3.Product summary
    • 13.4.4.Recent developments
  • 13.5.Merck KGaA,
    • 13.5.1.Company details
    • 13.5.2.Financial outlook
    • 13.5.3.Product summary
    • 13.5.4.Recent developments
  • 13.6.New England Biolabs
    • 13.6.1.Company details
    • 13.6.2.Financial outlook
    • 13.6.3.Product summary
    • 13.6.4.Recent developments
  • 13.7.Promega Corporation
    • 13.7.1.Company details
    • 13.7.2.Financial outlook
    • 13.7.3.Product summary
    • 13.7.4.Recent developments
  • 13.8.Takara Bio Inc.
    • 13.8.1.Company details
    • 13.8.2.Financial outlook
    • 13.8.3.Product summary
    • 13.8.4.Recent developments
  • 13.9.Thermo Fisher Scientific, Inc.
    • 13.9.1.Company details
    • 13.9.2.Financial outlook
    • 13.9.3.Product summary
    • 13.9.4.Recent developments
  • 13.10.Others

14.Conclusion

15.List of Abbreviations

16.Reference Links